Carlo CALENDA

10/07/2020 The draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor ✓ Adopté ▲ Pour 10/07/2020 A comprehensive European approach to energy storage ✓ Adopté ▲ Pour 10/07/2020 The Chemicals Strategy for Sustainability ✓ Adopté ▲ Pour 10/07/2020 A comprehensive Union policy on preventing money laundering and terrorist financing – the Commission’s Action Plan and other recent developments ✓ Adopté ▲ Pour 10/07/2020 The EU’s public health strategy post-COVID-19 ✓ Adopté ▲ Pour 10/07/2020 The revision of the guidelines for trans-European energy infrastructure ✓ Adopté ▲ Pour 10/07/2020 Emission limits and type-approval for internal combustion engines for non-road mobile machinery: transitional provisions in order to address the impact of COVID-19 crisis ✓ Adopté ▲ Pour 10/07/2020 Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease ✓ Adopté ▲ Pour 10/07/2020 Emission limits and type-approval for internal combustion engines for non-road mobile machinery: transitional provisions in order to address the impact of COVID-19 crisis ✗ Rejeté ▼ Contre 10/07/2020 Emission limits and type-approval for internal combustion engines for non-road mobile machinery: transitional provisions in order to address the impact of COVID-19 crisis ✗ Rejeté ▼ Contre 10/07/2020 Emission limits and type-approval for internal combustion engines for non-road mobile machinery: transitional provisions in order to address the impact of COVID-19 crisis ✗ Rejeté ▼ Contre 10/07/2020 Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease ✗ Rejeté ▼ Contre 10/07/2020 Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease ✗ Rejeté ▼ Contre 10/07/2020 Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease ✗ Rejeté ▼ Contre 10/07/2020 Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease ✗ Rejeté ▼ Contre 10/07/2020 Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease ✗ Rejeté ▼ Contre 10/07/2020 Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease ✗ Rejeté ▼ Contre 10/07/2020 European Parliament recommendation to the Council and the Commission concerning the conclusion of an agreement, under negotiation, between the European Union and New Zealand on the exchange of personal data between the European Union Agency for Law Enforcement Cooperation (Europol) and the New Zealand authorities competent for fighting serious crime and terrorism ✓ Adopté ● Abst. 09/07/2020 The draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor ✓ Adopté ▲ Pour 09/07/2020 The draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor ✓ Adopté ▲ Pour